• otv

Tag: Favipiravir

Fake Medicine
Panic Grips Berhampur Denizens Over Seizure Of Fake Medicines In Odisha

Following the seizure of huge quantity of fake anti-covid drugs in Cuttack, people in various towns including in Berhampur city are panicked in apprehension of circulation of fake drugs in their home town.

Fake anti-covid drug
Odisha Govt Orders Probe Into Fake Anti-Covid Drugs 'Favipiravir' Trade In Cuttack

A day after the State Drugs Control squad seized huge quantities of fake anti-covid drugs 'Favipiravir' in Cuttack, the State Health department has ordered a probe into the incident on Saturday.

Fake Drug Rackets On The Prowl In Rural Areas; Cheap Antibiotics Sold As Remdesivir
COVID19 Vaccine: India Gets 12L Favipiravir, 6.9L Remdesivir In Foreign Aid

Major consignments were received on May 23 and May 24 from United Arab Emirates (UAE), Singapore, Ontario (Canada), US-India Strategic Partnership Forum (USISPF) and Nestle (Swiss India Chamber of Commerce). The foreign relief aid includes 20 oxygen concentrators, 540 oxygen cylinders and 536 ventilators or Bi-PAP or CPAP.

Favipiravir: Flu Drug Shows Promise In Preventing Covid-19 Infection
Favipiravir: Flu Drug Shows Promise In Preventing Covid-19 Infection

London: The flu drug favipiravir has shown promise in preventing Covid-19 infection in rodents when administered in high doses, says a study. Further research will have to determine whether humans can tolerate a high dose of favipiravir, favipiravir — a broad-spectrum antiviral drug used in Japan to treat influenza — for four to five days. […]

India-COVID-19
COVID-19: Favipiravir To Be Provided To Home Isolation Patients In Odisha; Use, Dosage Details

Bhubaneswar: Odisha government’s Technical Advisor on COVID-19, Dr Jayant Panda on Monday said that the patients in home isolation can now get the antiviral drug, Favipiravir. The distribution of the drug will start in three cities- Cuttack, Bhubaneswar and Puri. He said that if Favipiravir is taken in the initial stage of a patient developing […]

Remdesivir
SC: Centre's nod for Remdesivir and Favipiravir for Covid-19, asks petitioner to study rules

New Delhi: The Supreme Court on Wednesday said the Centre has framed rules on drugs clinical trial and there is also an approval on the use of Remdesivir and Favipiravir as medicines to treat Covid-19. A bench headed by Chief Justice S A Bobde and comprising Justices A S Bopanna and V Ramasubramanian, citing the […]

FluGuard
COVID-19: Sun Pharmaceutical Launches Favipiravir As FluGuard At Rs 35

New Delhi: Sun Pharmaceutical Industries Ltd on Tuesday announced the launch of Favipiravir, under brand name FluGuard, at Rs 35 per tablet for the treatment of mild to moderate cases of Covid-19 in India. Favipiravir is an oral anti-viral treatment approved in India for the potential treatment of patients with mild to moderate Covid-19 disease. […]

Favipiravir
Cipla Gets DCGI Nod To Sell Favipiravir Under Brand 'Ciplenza'

Mumbai: Drug maker Cipla Ltd. on Friday said it has received regulatory approval from Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza to treat mild to moderate Covid-19 patients. Favipiravir is an off-patent, oral antiviral drug that has been shown to hasten clinical recovery […]

Fabiflu
Fighting COVID-19: Fabiflu More Economical & Effective Treatment Option, Claims Glenmark

New Delhi: In a strong rebuttal to the drug regulator, Glenmark Pharma said it has been at the receiving end of careless, unsubstantiated allegations that are devoid of merits related to Covid drug, Fabiflu. In a reply to V.G. Somani, Directorate General of Health Services, Central Drugs Standard Control Organisation, Glenmark has responded to allegations […]

Favipiravir
Covid-19 Drug Favipiravir Price Drops To Rs 75/Tablet In India

New Delhi: Drug firm Glenmark Pharmaceuticals on Monday said it has cut price of its antiviral drug Favipiravir under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19, by 27 per cent to Rs 75 per tablet. Glenmark Pharmaceuticals had launched FabiFlu last month at a price of Rs 103 […]

COVID-19-Medicine-Favipirav
India Pharma Company Glenmark Launches COVID19 Drug At Rs 103

Mumbai: Glenmark Pharmaceuticals on Saturday launched antiviral drug Favipiravir for treatment of mild-to-moderate Covid-19 cases after it received the Indian drug regulator’s approval. It will be available under the brand name FabiFlu as a prescription-based medication for Rs 103 per tablet, with a recommended dose of 1,800 mg twice a day on day 1 and […]